MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
SOPH Sophia Genetics
- 3.260
- +0.160+5.16%
Close Dec 20 16:00 ET
216.59MMarket Cap-2.99P/E (TTM)
3.310High3.160Low28.92KVolume3.170Open3.100Pre Close93.24KTurnover0.06%Turnover RatioLossP/E (Static)66.44MShares7.37052wk High1.91P/B154.14MFloat Cap2.70052wk Low--Dividend TTM47.28MShs Float19.800Historical High--Div YieldTTM4.84%Amplitude1.685Historical Low3.223Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Sophia Genetics Stock Forum
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
SOPHiA GENETICS (Nasdaq: SOPH) will present groundbreaking research at ESMO 2024, showcasing AI-driven patient stratification for non-small cell lung cancer (NSCLC) treatment.
The study, conducted with AstraZeneca, analyzed the POSEIDON Phase 3 clinical trial using multimodal machine learningto identify NSCLC patient subgroups most likely to benefit...
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
SOPHiA GENETICS (Nasdaq: SOPH) announced updates on SOPHiA UNITY, its global consortium for precision oncology research, at ESMO 2024. Several world-renowned healthcare organizations have joined the initiative, including Exactis Innovation in Canada, Institut Paoli-Calmettes in France, and potentially Gemelli Hospital in Italy. These institutions join inaugural member Memorial Sloan Kettering Cancer Cen...
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
SOPHiA GENETICS (Nasdaq: SOPH) announced a collaboration with Microsoft and NVIDIA to launch a whole genome sequencing (WGS) analytical solution by end of 2024. The new WGS application aims to deliver fully analyzed genome insights within the same day, enhancing research, drug discovery, and clinical care. Leveraging Microsoft Azure and NVIDIA Parabricks, the solution will provide scalable and rapid...
NEWS
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
Unilabs, a leading diagnostic provider in Europe, has implemented SOPHiA GENETICS' AI technology for HRD testing in solid tumors across its network in Switzerland. HRD, a common alteration in ovarian cancer, affects approximately half of newly diagnosed patients, making it a important factor in treatment planning. SOPHiA GENETICS' SOPHiA DDM™ Platform u...
SOPHiA GENETICS (SOPH) partners with Strand Life Sciences to advance precision medicine globally. The collaboration aims to provide innovative solutions leveraging genomics technologies and bioinformatics services.
No comment yet